award

Repurposing FDA-approved oxytocin to treat opioid-induced respiratory depression

  • Award Number: UG3DA062506

  • ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

  • OPDIV: NIH

  • AWARD CLASS: COOPERATIVE AGREEMENT

  • AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

  • PERIOD OF PERFORMANCE START DATE: 07/01/2025

  • PERIOD OF PERFORMANCE END DATE: 06/30/2027